COVID-19 UPDATES

Innovaderm continues to be fully operational remotely until further notice. Our teams are constantly re-evaluating and adapting project decisions based on each local deconfinement plans affecting our site and vendors.

 

As the situation for all clinical trials during the COVID-19 Public Health Emergency evolves rapidly, one of the focus is to continue allowing the proper capture of subject’s informed consent. To this effect, FDA is providing all investigators with a free platform they have developed in partnerships, now referred to as COVID MyStudies, allowing to obtain subjects’ informed consent electronically in a secured way.

 

Click on the link below for more details:

 

https://www.fda.gov/drugs/science-and-research-drugs/covid-mystudies-application-app?utm_campaign=MyStudies%20App%20OGCP&utm_medium=email&utm_source=Eloqua